The global Implantable Cardioverter Defibrillator (ICD) market size is expected to reach USD 8.81 Billion at a steady CAGR of 2.7% in 2028, according to latest analysis by Emergen Research. The market for implantable cardioverter defibrillators is growing due to an increase in prevalence of cardiac diseases. Surge in risk factors such as obesity and rise in sedentary lifestyle are other key factors driving the growth of ICD market.
Implantable cardioverter defibrillator is a small battery powered device placed on an individual’s chest to monitor heart rhythm and detect abnormal heartbeats. The device can deliver electric shocks via wires to fix heart arrhythmias. Rising prevalence of cardiovascular diseases and increase in global geriatric population are factors fueling growth of the market to a significant extent. Emergence of MRI-compatible implantable cardioverter defibrillator is also expected to contribute to market revenue growth. Upsurge in adoption of subcutaneous ICDs due to various benefits is also expected to fuel market revenue growth.
To know more about the report, visit @https://www.emergenresearch.com/industry-report/implantable-cardioverter-defibrillator-market
Market Scope:
One of the report’s central components is the broad Implantable Cardioverter Defibrillator market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders. The report contains unbiased industry expert opinions on the current market scenario, past market performance, production & consumption rates, demand & supply ratio, and revenue generation forecasts over the estimated period. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report.
Highlights of the TOC:
- Report Overview
1.1 Research Scope
1.2 Key Implantable Cardioverter Defibrillator market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline - Global Growth Trends
2.1 Global Implantable Cardioverter Defibrillator market size
2.2 Latest Implantable Cardioverter Defibrillator market trends
2.3 Key growth trends - Competitive Landscape
3.1 Global Implantable Cardioverter Defibrillator market key players
3.2 Global Implantable Cardioverter Defibrillator size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the Implantable Cardioverter Defibrillator market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances
Key geographical areas:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Leading Players Profiled in the Report:
Boston Scientific Corporation, Abbott Laboratories, Biotronik, Medtronic PLC, LivaNova PLC, MicroPort, Sorin Group, Koninklijke Philips N.V., Fukuda Denshi Co. Ltd., and Physio-Control, Inc.
Emergen Research has segmented the global implantable cardioverter defibrillator market on the basis of product type, end-use, and region:
- Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Transvenous ICD
- Single Chamber ICD
- Dual Chamber ICD
- CRT-D (cardiac resynchronization therapy-defibrillator)
- Subcutaneous ICD
- Transvenous ICD
- End-use Channel Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Others
Thank you for reading our report. For additional information on customization of the report, connect with us, and we will make sure you get a report tailored to your research needs.
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
